Are these tests a choice that is wise?
A decade ago, businesses started developing saliva-based, at-home hereditary tests that provide people the capability to find out about their traits that are genetic. These tests began with ancestry information, then developed to add faculties (such as for instance hair loss and locks color), predispositions for health problems (such as for example Parkinson’s infection and cancer of the breast), and reactions to particular medications. These “direct-to-consumer” (DTC) tests offer fast, cheap hereditary screening without the need to consult a physician… But is it a choice that is wise? And exactly how if the outcomes be interpreted and utilized?
Understand the restrictions: mail-order tests are neither comprehensive nor definitive
In March 2018, the usa Food and Drug management authorized DTC business 23andMe to report on risks pertaining to the BRCA1 and BRCA2 genes. These genes had been catapulted to fame in 2013 by Angelina Jolie, whom opened about her experience and preventative alternatives as a provider of a BRCA1 mutation. The BRCA1/2 genes are connected with a risk that is high breast and ovarian cancer tumors, and averagely increased dangers for any other cancers. It is crucial for almost any specific considering 23andMe specifically for the BRCA1/2 mutations to comprehend its restrictions.